Access cutting-edge inflammatory bowel disease treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.
Access inflammatory bowel disease specialists in Hartford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related inflammatory bowel disease treatment provided free
The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks and may include up to 44 visits. Additional treatment may be available to participants via a Continued Access Period.
Sponsor: Eli Lilly and Company
Check if you qualify for this inflammatory bowel disease clinical trial in Hartford, CT
If you're searching for inflammatory bowel disease treatment options in Hartford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammatory bowel disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.